Siam Bioscience was selected by AstraZeneca

23 Sept 03:22 Key points summarised by AI

AstraZeneca selected Siam Bioscience as a global manufacturing partner, positioning Thailand as the vaccine production hub for the ASEAN region.
Prime Minister Prayut warned the Kao Klai party against criticisms that could jeopardize vaccine procurement, while the NVI director defended the government's strategy, clarifying advanced payments for AstraZeneca versus COVAX.
Thailand announced its first phase plan to deploy two million Sinovac vaccine doses across 10 provinces for specific recipients from February to May.

Six injured after car smashes into On Nut shopping mall

Yesterday 22:44 Key points summarised by AI

A 67-year-old woman drove her car through the glass frontage of a Bangkok shopping mall, injuring six people, including a six-year-old girl.
The driver claimed she accidentally pressed the accelerator instead of the brake after being startled, causing the vehicle to surge forward.
She apologized to the victims, promising insurance coverage and additional financial aid, while police continue to gather statements before filing charges.